Surgical treatment of aspergillus fumigatus spondylitis in a cirrhotic patient: a rare case report Authors: Yunlong Zhou, Zhiqiang Liu, Hui Yu, Guiying Guo, Xing Yang, Junyu Zhang Published: 2024 ABSTRACT AbstractBackgroundFungal spondylitis often occurs in patients with immune dysfunction, and its diagnosis and treatment pose certain challenges. However, even in immunocompromised patients, Aspergillus spondylitis remains rare. This case reports the diagnostic and therapeutic experience of fungal spondylitis in a patient with consolidated cirrhosis and no significant immune impairment.Case presentationA 45-year-old agricultural worker had chest and back pain for 6 months. The patient’s pain was a persistent dull ache that worsened with chronic coughing and postural changes and decreased when he was laying down. Based on the patient’s clinical presentation, biochemical tests and imaging, considered possible spinal tuberculosis. Empirical anti-tuberculosis treatment was not successful. Due to the failure of medication and the formation of an epidural abscess, the decision was made to proceed with surgical treatment. Intraoperative tissue specimens were subjected to high throughput testing for culture, tuberculosis gene X-pert and high-throughput detection of macro-gene infectious agents. It was confirmed that the spinal infection was caused by Aspergillus fumigatus. Tuberculosis medication was ceased and antifungal therapy with voriconazole was started. Three months after surgery, the patient recovered well with no fever or pain.Discussion and conclusionIn summary, in addition to patients with low immune function who should be evaluated for fungal spondylitis, patients with infectious diseases of the spine who are immunocompetent but have comorbid cirrhosis should be evaluated when treatment fails. If the diagnosis cannot be made by conventional or unconventional methods, surgical methods should be used in a timely manner for diagnosis and treatment.Keywords: Case report, Spine, Spondylitis, Aspergillus Background Aspergillosis is an opportunistic fungal infection that primarily affects the respiratory tract and can be transmitted hematogenously to the spinal vertebrae, which then becomes Aspergillus spondylitis, but rarely infects patients with normal immunity [1]. It is commonly seen in patients with HIV, severe neutropenia, glucocorticoids intake, transplantation and other immunosuppressive conditions [2]. When it occurs, vertebral fungal disease is a rare and seriously life-threatening condition that requires long-term drug treatment and usually surgery. Currently, although the incidence of vertebral fungal disease is steadily increasing, it occurs mainly in hosts with compromised immune function [3]. Similarly, Aspergillus spondylitis are less likely to affect patients with normal immune function. In this article, we present a case of Aspergillus fumigatus spondylitis misdiagnosed as spinal tuberculosis and review the diagnostic and therapeutic management of these cases. There are only a few relevant reports at present, and most of these are in immunocompromised patient. The patient’s medical history was only remarkable for chronic cirrhosis, associated with hepatitis B. There were no abnormalities in liver function, much less significant immunosuppression. To the best of our knowledge, there are currently no relevant reports of this type in China. This study is reported according to the Surgical Case Reporting Guidelines (SCARE 2020) [4]. Presentation of case A 45-year-old agricultural worker had chest and back pain for 6 months. The patient’s pain was a persistent dull ache that was aggravated by chronic coughing and changes in posture and relieved by lying flat. The patient had lost 15 kg of weight in six months. He then presented to our outpatient department. Physical examination revealed significant tenderness and rebound pain over the 7th and 8th spinous processes of the thoracic spine. On completion of relevant investigations in the outpatient department, the patient had a normal total white blood cell count, normal monocytes and lymphocytes, a normal total red blood cell count, a platelet count of 80*10^9/L, no abnormalities in tumour markers and no abnormalities in the antinuclear antibody spectrum; Hepatitis B surface antigen (+), Hepatitis B surface antibody (-), Hepatitis B E antigen (-), Hepatitis B E antibody (-), Hepatitis B core antibody (-); no apparent abnormalities in liver function; erythrocyte sedimentation rate (ESR) 11 mm/h; plasma C-reactive protein (CRP) 51 mg/L; procalcitonin (PCT) 0. 079ng/ml; and TB-IGRA (T-N) 776.66, the result was determined to be positive (Table 1. Preoperative relevant biochemical tests in patients). Abdominal ultrasound showed signs of cirrhosis (He was diagnosed with cirrhosis of the liver last year at an another hospital), while chest Computed tomography (CT) scan showed chronic inflammation of the lungs (Few fibrous bands in both lungs with mild pleural thickening). Magnetic Resonance Imaging (MRI) of the thoracic vertebrae showed bone destruction and paravertebral abscess formation in the 7th-8th thoracic vertebrae (Fig. 1. Patient’s thoracic MRI examination). The patient had no specific medication history, family history (including any relevant genetic information), or psychosocial history. Based on the patient’s clinical presentation, biochemical tests and imaging, spinal tuberculosis was considered and the patient was commenced on empirical anti-tuberculosis treatment, including oral Isoniazid tablets, 300 mg once a day, oral Rifampicin tablets, 450 mg once a day, oral Pyrazinamide tablets, 500 mg once a day. Table 1Preoperative relevant biochemical tests in patientsTest itemslaboratory resultregular valueWBC4.90*10^9/L3.5–9.5*10^9/LNE3.26*10^9/L1.6–6.3*10^9/LLYM1.21*10^9/L1.1–3.2*10^9/LPlatelet80 *10^9/L100–325*10^9/LHBsAg(+)(-)Anti-HBs(-)(-)HBeAg(-)(-)Anti-HBe(-)(-)Anti-HBc(-)(-)ESR11 mm/h0–15 mm/hCRP51 mg/L0-5 mg/LPCT0.079ng/ml<0.05TB-IGRA (T-N)776.660–14 Preoperative relevant biochemical tests in patients Patient’s thoracic MRI examination (1.a. Sagittal section T1 serial phase of the thoracic spine; 1.b. Sagittal section T2 serial phase of the thoracic spine; 1.c. Sagittal section T2 sequence of the thoracic spine for lipid-suppressive phases. All three views show epidural abscess formation in the thoracic spine) During hospitalisation, the patient developed low-grade fever and had negative sputum and blood cultures. After 2 weeks of anti-tuberculosis treatment, the patient’s CRP was 43.29 mg/L; PCT 0.067ng/ml. The patient’s chest and back pain did not decrease, however his symptomatic improvement of respiratory complaints. Review of the patient’s thoracic spine magnetic resonance revealed that it did not look like thoracic spine tuberculosis, but more like septic spondylitis with epidural abscess formation (because the destruction of the intervertebral discs was more pronounced, whereas the destruction of the vertebral bodies was less pronounced). After reviewing the patient’s imaging and clinical features in a multidisciplinary meeting, the decision was made to intervene surgically due to the failure of medication and the formation of an epidural abscess. Three weeks after initiation of medical treatment, the patient was subjected to a one-stage posterior surgical debridement, fusion, and internal fixation. During the operation, samples were taken for microbiological and pathological examination (Fig. 2. Histopathologic images of intraoperative sampling). The drains were flushed slowly and continuously for one week postoperatively using saline. Anti-tuberculosis treatment was continued while awaiting the results of the tests. The X-pert tuberculosis gene test result obtained during surgery was negative. Aspergillus infection was detected by culture (Fig. 3. The colony images detected through this cultivation). The colonies of Aspergillus fumigatus grow rapidly, usually fluffy or flocculent, with the colour gradually changing from white to smoky green and dark green. Its conidium head short columnar, length varies, conidium peduncle smooth, near the tip of the expansion of the formation of inverted flask-shaped capsule. Aspergillus was detected with a sequence number of 828 and a relative abundance of 74.86 (Aspergillus fumigatus with sequence number 533); the bacterial list was not detected; the list of Mycobacterium tuberculosis complex groups was not detected; the parasite list was not detected; the Mycoplasma/Chlamydia list was not detected. After the test results were reported, the doctor stopped the anti-tuberculosis medication and started oral antifungal treatment with voriconazole at 200 mg every 12 h. Histopathologic images of intraoperative sampling (Arrows point to Aspergillus fumigatus) The colony images detected through this cultivation (3.a. Microscopic staining examination after culture revealed Aspergillus fumigatus; 3.b. Aspergillus fumigatus shown by culture) Following posterior spinal debridement, fusion and internal fixation, the patient experienced significant relief of chest and back pain. He has been taking voriconazole for 3 months and his clinical symptoms have continued to improve. Radiological assessment at 3 months postoperatively showed pinned rods in place and some fusion of the vertebrae (Fig. 4. Digital Radiography taken during the follow-up period three months after surgery). Both ESR and PCT have become negative. The patient is still taking voriconazole and is expected to remain on antifungal treatment for one year. Digital Radiography taken during the follow-up period three months after surgery (4.a. Frontal view thoracic spine Digital Radiography; 4.a. lateral thoracic spine Digital Radiography; Radiological assessment at 3 months postoperatively showed pinned rods in place and some fusion of the vertebrae) Discussion Aspergillosis is a rare disease with an estimated incidence of 12 cases/100,000 people per year [5]; Aspergillus spondylitis is an even rarer opportunistic fungal infection with devastating consequences. Most patients with Aspergillus spondylitis are associated with impaired immune function (HIV, severe neutropenia, glucocorticoid intake, transplant and other immunosuppressive conditions). However, cases have been reported in immunocompetent hosts without risk factors [6]. To the best of our knowledge, this is the first case of Aspergillus spondylitis in China that was only combined with compensated cirrhosis of the liver and had no associated risk factors (e.g., recent history of surgery, invasive operations, and tuberculosis). The most common symptom of Aspergillus spondylitis is pain in the vertebral body at the site of infection, with or without fever [7]. However, if the infection progresses to a certain level and an epidural abscess, symptoms of spinal nerve compression or even paraplegia may occur. Because of the insidious nature of mycotic spondylitis, the lack of specific clinical manifestations, and the very low incidence rate, there is a degree of difficulty in diagnosing patients. The diagnosis can usually only be confirmed by biopsy. If haematological (ESR, CRP, fungal G-test, etc.) and imaging studies suggest Aspergillus spondylitis, CT-guided puncture biopsy should be performed as early as possible to clarify the diagnosis and guide antibacterial treatment [8]. Compared with bacterial purulent spondylitis, these tests are not specific for fungal purulent spondylitis. The most reliable diagnostic methods for Aspergillus spondylitis are histopathological examination and bacterial culture. The diagnosis in the case of this article was similar in that we considered it to be a possible bacterial pyogenic spondylitis before the results of our sampling were shown back, and only after the biopsy results were shown back was it determined to be Aspergillus fumigatus spondylitis. Therefore, after performing the biopsy, we did not perform an immunization study to determine the immune status. Once Aspergillus spondylitis occurs, the infection is difficult to control and it is often necessary to be combined medication with surgery to long-term treatment. The purpose of surgery is to obtain samples when necessary and to perform decompression in the event of an epidural abscess, spinal instability or neurological symptoms. Voriconazole is an antifungal agent introduced in 2003 and is the preferred treatment for invasive aspergillosis, including Aspergillus spondylitis [9]. This agent is more potent and less toxic than amphotericin B and can achieve better clinical efficacy. It can be given orally and can achieve an inhibitory concentration of Aspergillus above the typical minimum bone concentration. Other therapeutic agents include liposomal or liposomal formulations of amphotericin B and isavuconazole, while other therapeutic methods used for curative treatment include caspofungin, micafungin, anidulafungin, posaconazole and itraconazole [9, 10]. Currently, there is limited experience of treating Aspergillus spondylitis with voriconazole, but the updated 2016 American Society of Infectious Diseases guidelines currently recommend treatment for at least 8 weeks, with longer treatment (> 6 months) usually required [10]. In our case, after combining and referring to existing treatment plans for fungal spinal infections [11], combined with poor patient compliance, we decided to increase the duration of drug use (> 6 months) and discontinue the drug depending on follow-up. Conclusion Once Aspergillus spondylitis occurs, the consequences are very serious. Again, diagnosis and treatment of Aspergillus spondylitis are often challenging, which can lead to misdiagnosis or delayed treatment, resulting in poor efficacy. In addition to patients with low immune function who should be evaluated for fungal spondylitis, patients with initially normal immune function but with comorbid cirrhosis should also be considered for fungal spondylitis when treatment is not effective. If the diagnosis cannot be made by conventional or unconventional methods, surgical methods should usually be used in a timely manner for diagnosis and treatment, and antibacterial treatment plans should be changed promptly after diagnosis following surgery. However, it is important to communicate fully with patients and their families about surgical complications and potential adverse outcomes. Acknowledgements None. Author contributions Yunlong Zhou and Zhiqiang Liu are the co-first author and they contributed equally to this article. Y.Z. performed the operationand and wrote the manuscript; Z.L. case report data collection, assisted in the operation; H.Y. and G.G. cultivation and testing of biopsy tissue obtained through surgery; X.Y. patient consent; J.Z. assisted in the operation, case report concept, design, and made modifications to the manuscript. All authors reviewed the manuscript. Funding No funding was provided/utilized during the course of the study. Data availability Data is provided within the manuscript or supplementary information files. Declarations Ethics approval and consent to participate N/A. Patient consent was obtained to store, analyze, and publish the fndings. Patient has been de identifed. Consent for publication Written informed consent was obtained from the patient/participant for the publication of this case report and accompanying images in an open access online publication. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Data Availability Statement Data is provided within the manuscript or supplementary information files.